文献速递糖尿病

2型糖尿病及早期糖尿病多发性神经病变中血清神经丝轻链的纵向变化:ADDITION-Denmark研究

Longitudinal Change in Serum Neurofilament Light Chain in Type 2 Diabetes and Early Diabetic Polyneuropathy: ADDITION-Denmark.
PubMed 文献 · Diabetes Care · 2024-01-01

基于ADDITION-Denmark队列178例筛查发现的2型糖尿病患者,回顾性纵向病例对照分析显示,伴与不伴糖尿病多发性神经病变(DPN)者血清神经丝轻链(s-NfL)均随时间升高且高于正常年龄相关升高幅度,伴DPN者纵向升高幅度更大;s-NfL年增长越高与DPN风险越高相关(每1 ng/L/年OR 1.36)。

要点

  • 伴与不伴DPN者s-NfL均随时间升高,且高于正常年龄相关升高水平。
  • 伴DPN者s-NfL或NfL z-score纵向升高幅度大于不伴DPN者(高17.4%或0.31 SD)。
  • s-NfL年增长越高与DPN风险越高相关(每1 ng/L/年OR 1.36)。

核心结论

  • 研究提示伴与不伴DPN者的s-NfL轨迹略有差异,并暗示s-NfL轨迹可能具有DPN生物标志物价值。

研究设计与样本

  • 对ADDITION-Denmark队列中178例筛查发现的2型糖尿病患者进行回顾性纵向病例对照分析。
  • 采用单分子阵列检测5年和10年随访生物样本中的s-NfL,并与既定参考材料比较获得NfL z-score。
  • DPN按Toronto标准在10年随访时诊断为确诊DPN。

主要发现

  • 伴DPN(N=39)与不伴DPN(N=139)者s-NfL均随时间升高,且高于正常年龄相关s-NfL升高水平。
  • 伴DPN者较不伴DPN者s-NfL或NfL z-score纵向升高更多:高17.4%(95%CI 4.3;32.2)或高0.31 SD(95%CI 0.03;0.60)。
  • 5年随访时s-NfL与10年随访时神经传导研究呈正相关(P=0.02至<0.001),但与DPN风险无关。
  • s-NfL的曲线下面积(AUC)不劣于密歇根神经病变筛查量表问卷评分或振动检测阈值的AUC。
  • s-NfL年增长越高与DPN风险越高相关(每1 ng/L/年OR 1.36,95%CI 1.08;1.71)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the longitudinal development of neurofilament light chain (NfL) levels in type 2 diabetes with and without diabetic polyneuropathy (+/-DPN) and to explore the predictive potential of NfL as a biomarker for DPN. RESEARCH DESIGN AND METHODS: We performed retrospective longitudinal case-control analysis of data from 178 participants of the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care-Denmark (ADDITION-Denmark) cohort of people with screen-detected type 2 diabetes. Biobank samples acquired at the ADDITION-Denmark 5- and 10-year follow-ups were analyzed for serum NfL (s-NfL) using single-molecule array, and the results were compared with established reference material to obtain NfL z-scores. DPN was diagnosed according to Toronto criteria for confirmed DPN at the 10-year follow-up. RESULTS: s-NfL increased over time in +DPN (N = 39) and -DPN participants (N = 139) at levels above normal age-induced s-NfL increase. Longitudinal s-NfL change was greater in +DPN than in -DPN participants (17.4% [95% CI 4.3; 32.2] or 0.31 SD [95% CI 0.03; 0.60] higher s-NfL or NfL z-score increase in +DPN compared with -DPN). s-NfL at the 5-year follow-up was positively associated with nerve conduction studies at the 10-year follow-up (P = 0.02 to <0.001), but not with DPN risk. Areas under the curve (AUCs) for s-NfL were not inferior to AUCs for the Michigan Neuropathy Screening Instrument questionnaire score or vibration detection thresholds. Higher yearly s-NfL increase was associated with higher DPN risk (odds ratio 1.36 [95% CI 1.08; 1.71] per 1 ng/L/year). CONCLUSIONS: Our findings suggest that preceding s-NfL trajectories differ slightly between those with and without DPN and imply a possible biomarker value of s-NfL trajectories in DPN.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Määttä LL, Andersen ST, Parkner T, et al. Longitudinal Change in Serum Neurofilament Light Chain in Type 2 Diabetes and Early Diabetic Polyneuropathy: ADDITION-Denmark. Diabetes Care. 2024. PMID: 38502878. doi:10.2337/dc23-2208

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。